Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature
Malignant tumors, characterized by uncontrolled cell proliferation, are a leading global health challenge, responsible for over 9.7 million deaths in 2022, with new cases expected to rise to 35 million annually by 2050. Immunotherapy is preferred to other cancer therapies, offering precise targeting...
Saved in:
Main Authors: | Angus Nnamdi Oli, Samson Adedeji Adejumo, Adekunle Babajide Rowaiye, Joyce Oloaigbe Ogidigo, Jarrad Hampton-Marcell, Gordon C. Ibeanu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2024/8481761 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review
by: Adekunle Babajide Rowaiye, et al.
Published: (2024-03-01) -
Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response
by: Benjamin H. Jenkins, et al.
Published: (2025-01-01) -
Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy
by: S. J. Luk, et al.
Published: (2024-12-01) -
Response of Immunotherapy to Tumour-TICLs Interactions: A Travelling Wave Analysis
by: Joseph Malinzi, et al.
Published: (2014-01-01) -
BRM Immunotherapy of Orthotopically Implanted Murine Bladder Tumours: Treatment Response by Monitoring MRI
by: Salam A Kadhim, et al.
Published: (1992-01-01)